Provider review · Public documents checked September 27, 2026
The Ordinary Copper Peptides 1% review: a number within a formula
What the product name, ingredient declaration and current offer can establish—and what they cannot isolate.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
One percent is easy to remember; a long ingredient declaration is not. That difference can make The Ordinary's Multi-Peptide + Copper Peptides 1% Serum seem simpler than the record actually describes. The number appears within a product containing several peptide technologies and other ingredients. It should not stand in for the entire formula when comparing outcomes, tolerance or price.
This review comes from Percentage, Please, part of CoreAge Rx's promotional publishing network. CoreAge receives the disclosed first commercial place in our comparison. The Ordinary's public records were checked on September 27, 2026; we did not apply the serum, test its composition, obtain patient results or independently validate its appearance claims.
In this article
Keep the complete name attached to the number
The current product is named Multi-Peptide + Copper Peptides 1% Serum, with the previous name Buffet + Copper Peptides 1% noted by the manufacturer. The record identifies a water-based serum and describes several peptide technologies, amino acids and hyaluronic-acid ingredients. This is more specific than a reference to an unspecified one-percent copper product. Manufacturer page.
The full name helps distinguish the product from other items in the brand's range and from another company's formula. The commercially disclosed comparison uses that identity as the starting point. It does not assume that similarly named ingredients create identical preparations or directly comparable percentage systems.
The ingredient declaration provides names, not every answer
The current list includes Copper Tripeptide-1, Lactococcus Ferment Lysate and several additional peptides, as well as glycerin, hyaluronates and other formulation ingredients. The manufacturer also describes GHK-Cu in the product explanation. These are useful attributed details; they do not constitute this publication's measurement of content, ingredient quality or delivery into skin.
FDA's cosmetic labeling guide explains the declaration framework and its ordering qualifications, including the treatment of ingredients present at no more than 1%. A reader cannot reconstruct an exact formula merely from list position. FDA guide. The grade-and-purity guide separates the information in a declaration from claims requiring analytical evidence.
More named technologies do not isolate the active contribution
The Ordinary describes the serum as addressing visible signs such as fine lines, elasticity and texture. Because those claims concern a multi-ingredient product, an observed difference would not automatically identify copper as the sole explanation. The same limitation would apply to attributing a reaction only to the ingredient named most prominently.
General skin-care guidance also needs its own boundary. AAD discusses moisturizers and ingredients such as glycerin or hyaluronic acid in the context of dryness during menopause. That does not establish this particular serum's results, required role or comparative advantage. AAD guidance. The outcome-vocabulary guide explains why hydration and wrinkle measurements should not collapse into one claim.
Product restrictions remain part of its record
The manufacturer advises against combining this serum with direct acids, retinoids and strong antioxidants such as vitamin C. It also restricts its instructions to unbroken skin and acknowledges the possibility of irritation. These qualifications should remain visible beside broad descriptions such as suitability for all skin types.
This review does not turn those directions into a universal rule about every copper peptide or provide a personal sequence for using products together. Different preparations can have different instructions. A claim that one formula is stronger or gentler cannot be established by comparing how reassuring their product pages sound. The CoreAge review applies the same scrutiny to its provider's gentleness and grade language.
An ingredient study is not the same as this product’s trial
A frequently relevant copper-tripeptide abstract describes post-laser care, not a routine-use trial of the current Ordinary serum. Its thirteen completers received regimens with or without GHK-Cu after resurfacing around the mouth. Objective between-group differences in the assessed appearance outcomes were not significant, while questionnaire satisfaction favored the copper-peptide regimen. Primary abstract.
The abstract does not establish the supplied preparation as this serum, and we did not inspect the complete study report. Its favorable satisfaction finding should not be presented as proof of a wrinkle effect from the Ordinary product. The study-endpoint review keeps the setting, preparation uncertainty and outcome distinctions together.
The current price is a retail observation
The checked United States record identified the 30 mL option at $28.80 with a $32 reference price. Those figures reflect the observed offer, not a promised future discount or a completed checkout. A lower bottle price is not already a lower cost for an equivalent treatment course because the compared products do not have an established common course or supplied quantity.
The page also says formulas are updated and ingredient lists can differ from the box according to time and region of purchase. That caveat matters when comparing a current record with an older bottle or review. The price article distinguishes dated bottle offers from monthly-equivalent plan language.
One percent should not become a performance rank
The Ordinary's headline cannot demonstrate that the serum is half as effective as an advertised 2% preparation. Nor does NIOD's description of two separate one-percent components establish that its serum has twice this product's copper content. The NIOD CAIS3 analysis explains why the names attached to those components matter.
A useful review can establish the current product identity, the manufacturer's claims, the formulation information disclosed and the offer observed. It cannot bridge absent analytical specifications or comparative trials with arithmetic. Keeping those limits explicit gives the reader a better question to ask than which printed number wins.
Sources behind this reading
- The Ordinary Multi-Peptide + Copper Peptides 1% Serum product record ↗Manufacturer product page · Checked 2026-09-27
- FDA Cosmetics Labeling Guide ↗Regulator labeling guidance · Checked 2026-09-27
- American Academy of Dermatology: menopause skin care ↗Medical society patient guidance · Checked 2026-09-27
- Topical copper tripeptide complex after CO2 resurfacing: original study abstract ↗Primary clinical-study abstract · Checked 2026-09-27